COMMUNIQUÉS West-GlobeNewswire

CeCors, Inc. to Acquire 100% of Medical Records and Data Company
05/08/2019
LAS VEGAS, NV, Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CeCors, Inc. (OTC PINK:CEOS) ; a Company focused on the Health & Technology Sector as well as other Emerging Technologies, is pleased to update [...]
Therapeutic Solutions International Collaborates with Right to Try Foundation on Novel Means of Protecting Patients While Hyper-accelerating Drug Development
05/08/2019
Company Plans to Advance its Phase I Cancer Immunotherapy StemVacs™ to US Patients OCEANSIDE, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Therapeutics Solutions International, Inc., ( OTC Markets: TSOI [...]
Brazil Issues Vystar Patent Notice of Allowance for Deproteinization of Vytex Natural Rubber Latex
05/08/2019
WORCESTER, Mass., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Vystar Corp. (OTC Market: VYST) has received a notice of allowance from Brazil for a patent titled “Natural Rubber Latex Having Reduced Allergenicity and Method of [...]
Arch Therapeutics Announces AC5 Self-Assembling Peptide Technology Platform Demonstrates Antimicrobial Activity in Two Studies and Provides CE Marking Status Update for AC5™ Topical Hemostat
05/08/2019
Studies highlight antimicrobial activity for AC5 technology platform; AC5™ Topical Hemostat 1 under Review by Notified Body FRAMINGHAM, Mass., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (" [...]
Novo Nordisk A/S – Share repurchase programme
05/08/2019
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 5 August 2019 – On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European [...]
Minerva Neurosciences Reports Second Quarter 2019 Financial Results and Business Updates
05/08/2019
During the Second Quarter, Minerva announced several important clinical advancements, including positive top line results from two Phase 2b studies of seltorexant (MIN-202) in major depressive disorder (MDD) and [...]
Alkahest Announces Positive Top-line Data from Phase 2 Study in Mild to Moderate Alzheimer’s Disease
05/08/2019
SAN CARLOS, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical-stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today announced top-line data [...]
VIVUS Announces Approval of Qsymia® in the Republic of Korea
05/08/2019
VIVUS receives $2.5 million milestone payment CAMPBELL, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the “Company”), a biopharmaceutical company, announced today that its Korean marketing partner [...]
Kiniksa Pharmaceuticals Announces Collaboration with the Myocarditis Foundation for the Pericarditis Community
05/08/2019
HAMILTON, Bermuda, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic [...]
Intra-Cellular Therapies to Host Conference Call to Provide Regulatory Update Following Recent Meeting with FDA
05/08/2019
Agreement reached with FDA on submission of additional non-clinical information for NDA review of lumateperone for the treatment of schizophrenia Lumateperone PDUFA goal date extended three months to December 27, 2019 [...]
Theratechnologies’ CFO to Attend 39ᵗʰ Annual Growth Conference Held by Canaccord Genuity in Boston
05/08/2019
MONTREAL, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Philippe Dubuc, Senior Vice President and Chief Financial Officer, will attend the 39 th [...]
Le chef de la direction financière de Theratechnologies assistera à la 39ᵉ Annual Growth Conference tenue par Canaccord Genuity à Boston
05/08/2019
MONTRÉAL, 05 août 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que Philippe Dubuc, vice-président sénior et chef de la direction financière assistera à la 39 e [...]
Arbutus Reports Second Quarter 2019 Financial Results and Provides Corporate Update
05/08/2019
- Appointed William Collier , with decades of leadership experience in antivirals, President & CEO - Announced preliminary Phase 1a/1b clinical trial results demonstrating that AB-506 is a potent capsid inhibitor in [...]
BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
05/08/2019
RESEARCH TRIANGLE PARK, N.C., Aug. 05, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted six newly-hired [...]
Allakos Reports Second Quarter 2019 Financial Results
05/08/2019
REDWOOD CITY, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing AK002 for the treatment of eosinophil and mast cell related diseases, today [...]
The Joint Corp. Increases Corporate Clinic Portfolio by Two, to Reach 57
05/08/2019
Acquires Clinic in South Carolina Market, Expanding New Corporate Market Opens Greenfield in El Cajon, Broadening the San Diego Portfolio SCOTTSDALE, Ariz., Aug. 05, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: [...]
Altimmune to Announce Second Quarter 2019 Financial Results on August 14
05/08/2019
GAITHERSBURG, Md., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical stage biopharmaceutical company focused on developing liver disease and immune modulating therapies, today announced that it [...]
FH Ortho Receives Regulatory Clearance in Japan for its Arrow® Prime Anatomic Shoulder System
05/08/2019
MULHOUSE, France, Aug. 05, 2019 (GLOBE NEWSWIRE) -- FH Ortho, a manufacturer of orthopedic devices and instruments for surgeons around the world, announced it has received approval from the Pharmaceuticals and Medical [...]
Invitation: Terveystalo H1 Result – Webcast and Conference Call on 8 August 2019
05/08/2019
Terveystalo Plc will publish its half-year report for 2019 on 8 August at 9:00 EEST. (Finnish time). Materials are available after publication at: https://www.terveystalo.com/en/investors/Financial-information/ [...]

Pages